↓ Skip to main content

Aripiprazole for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs
1 blog
twitter
9 tweeters
weibo
1 weibo user

Citations

dimensions_citation
87 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole for schizophrenia
Published in
Cochrane database of systematic reviews, April 2006
DOI 10.1002/14651858.cd004578.pub3
Pubmed ID
Authors

Hany George El-Sayeh, Carla Morganti

Abstract

Treatment of people with schizophrenia using older typical antipsychotic drugs such as haloperidol can be problematic. Many fail to respond to these older antipsychotics and more people experience disabling adverse effects. Aripiprazole is said to be one of a new generation of atypical antipsychotics with good antipsychotic properties and minimal adverse effects.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
United States 1 <1%
Spain 1 <1%
Norway 1 <1%
Unknown 101 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Student > Bachelor 18 17%
Student > Postgraduate 11 10%
Student > Ph. D. Student 11 10%
Researcher 11 10%
Other 22 21%
Unknown 13 12%
Readers by discipline Count As %
Medicine and Dentistry 46 43%
Psychology 12 11%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Neuroscience 4 4%
Other 14 13%
Unknown 14 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2017.
All research outputs
#812,721
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#2,425
of 8,923 outputs
Outputs of similar age
#10,792
of 144,963 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 100 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.